Literature DB >> 23082992

Epidemiological patterns of perniosis, and its association with systemic disorder.

Z Takci1, G Vahaboglu, H Eksioglu.   

Abstract

BACKGROUND: There are few studies exploring the epidemiological properties of perniosis (chilblains) and its association with systemic disorders. AIM: To collect epidemiological data for perniosis, to investigate any association with systemic disorders, and to identify markers for the differential diagnosis of idiopathic and secondary perniosis.
METHODS: This was a prospective study of 51 patients with perniosis [female : male ratio 2.64 : 1, mean ± SD age 24.6 ± 14.7 years, with 25 patients (49%) aged 0-18 years]. Each patient was interviewed, and signs suggestive of connective-tissue disorders were recorded. Detailed laboratory investigations including autoimmune parameters were performed.
RESULTS: Significant proportions of the patients had both chronic and idiopathic perniosis (P < 0.001 for both). The mean age of the group with secondary perniosis was significantly higher than that of the idiopathic group (P < 0.01). There was no significant gender difference in the secondary perniosis group (P = 0.71). Clerking work was the most common occupation (37%, P = 0.01). Persistence beyond the cold seasons, and presence of photosensitivity, hypergammaglobulinaemia and rheumatoid factor were significant findings in the secondary group (P = 0.02, P = 0.02, P < 0.01, P < 0.05, respectively).
CONCLUSIONS: Perniosis is not rare in children, but patients with secondary perniosis are more likely to be older. In terms of underlying systemic disorder, advanced age and male gender may be important demographic features. Measurement of cryoglobulin levels in the initial laboratory investigations of patients with perniosis is not necessary. Persistence beyond the cold seasons, and presence of photosensitivity, hypergammaglobulinaemia and rheumatoid factor may be useful in differentiating between idiopathic and secondary perniosis. © The Author(s). CED
© 2012 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23082992     DOI: 10.1111/j.1365-2230.2012.04435.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  9 in total

Review 1.  Non-Atherosclerotic Vascular Disease in Women.

Authors:  Lee Joseph; Esther S H Kim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-14

2.  Chilblains in Turkey: a case-control study.

Authors:  Z Meltem Akkurt; Derya Ucmak; Kenan Yildiz; Safiye Kutlu Yürüker; Heybet Özkaya Celik
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

3.  Penile Chill Blains: a Case Report.

Authors:  Tanmay Pande; Amit Agrawal
Journal:  Indian J Surg       Date:  2021-05-22       Impact factor: 0.437

Review 4.  Chilblains in Southern California: two case reports and a review of the literature.

Authors:  Rebecca Gordon; Anne M Arikian; Anita S Pakula
Journal:  J Med Case Rep       Date:  2014-11-22

5.  Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19.

Authors:  I Torres-Navarro; C Abril-Pérez; J Roca-Ginés; J Sánchez-Arráez; R Botella-Estrada; M Évole-Buselli
Journal:  Clin Exp Dermatol       Date:  2020-05-24       Impact factor: 3.470

6.  Posttraumatic unilateral perniosis: A case report.

Authors:  Celeste Mirte Boesjes; Bram Doron van Rhijn; Marijke Regina van Dijk; Vigfús Sigurdsson
Journal:  JAAD Case Rep       Date:  2019-10-03

7.  Chilblains in immune mediated inflammatory diseases: a review.

Authors:  Shirish Dubey; Nilay Joshi; Olivia Stevenson; Caroline Gordon; John A Reynolds
Journal:  Rheumatology (Oxford)       Date:  2022-04-12       Impact factor: 7.046

8.  Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.

Authors:  L Le Cleach; L Dousset; H Assier; S Fourati; S Barbarot; C Boulard; C Bourseau Quetier; L Cambon; C Cazanave; A Colin; E Kostrzewa; C Lesort; A Levy Roy; F Lombart; J Marco-Bonnet; J-B Monfort; M Samimi; M Tardieu; P Wolkenstein; E Sbidian; M Beylot-Barry
Journal:  Br J Dermatol       Date:  2020-08-09       Impact factor: 11.113

9.  Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?

Authors:  A Ramondetta; M Panzone; P Dapavo; M Ortoncelli; M T Giura; M Licciardello; G Rozzo; N Siliquini; M T Fierro; S Ribero
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-08       Impact factor: 9.228

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.